DOI:
10.1055/s-00050348
Indian Journal of Medical and Paediatric Oncology
LinksClose Window
References
Nathan PC, Whitcomb T, Wolters PL, Steinberg SM, Balis FM, Brouwers P. et al.
Very high-dose methotrexate (33.6 g/m (2)) as central nervous system preventive therapy for childhood acute lymphoblastic leukemia: Results of national cancer institute/Children's cancer group trials CCG-191P, CCG-134P and CCG-144P.
Leuk Lymphoma 2006;
47: 2488-504
We do not assume any responsibility for the contents of the web pages of other providers.